找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Artificial Oxygen Carrier; Its Frontline Koichi Kobayashi (Chief Professor of Surgery),Eish Conference proceedings 2005 Springer-Verlag Tok

[復制鏈接]
樓主: 聲音會爆炸
41#
發(fā)表于 2025-3-28 17:09:04 | 只看該作者
42#
發(fā)表于 2025-3-28 20:41:08 | 只看該作者
Isolation and Culture of Skin Fibroblastsing a hemoglobin (Hb)-based oxygen carrier. In this chapter, we have summarized the characteristics and performances of Hb-vesicles (HbV) that have been developed on the basis of molecular assembly. Collaborative in vitro and in vivo studies have revealed sufficient safety and efficacy of HbV.
43#
發(fā)表于 2025-3-28 23:46:29 | 只看該作者
44#
發(fā)表于 2025-3-29 04:19:03 | 只看該作者
45#
發(fā)表于 2025-3-29 07:23:06 | 只看該作者
978-4-431-54636-8Springer-Verlag Tokyo 2005
46#
發(fā)表于 2025-3-29 12:24:26 | 只看該作者
Safety and Efficacy of Hemoglobin-Vesicles and Albumin-Hemes,s have been selected from the viewpoints of safety, efficacy, and cost performance. One is Hemoglobin-vesicles (HbV) and the other is albumin-heme (rHSA-heme). This chapter summarizes our video presentation that introduced the recent results of our research into HbV and rHSA-heme.
47#
發(fā)表于 2025-3-29 18:35:43 | 只看該作者
Hemoglobin-Vesicles (HbV) as Artificial Oxygen Carriers,ing a hemoglobin (Hb)-based oxygen carrier. In this chapter, we have summarized the characteristics and performances of Hb-vesicles (HbV) that have been developed on the basis of molecular assembly. Collaborative in vitro and in vivo studies have revealed sufficient safety and efficacy of HbV.
48#
發(fā)表于 2025-3-29 22:17:19 | 只看該作者
Intravascular Microbubbles: An Ultra-Effective Means of Transporting Oxygen,able to transport physiologically significant amounts of oxygen in animal experiments. Thus, the treatment sustained life in rats and pigs with potentially fatal erythrocytopenia caused by hemorrhage and hemodilution, and adequate oxygenation was preserved in severe right-to-left circulatory shunts caused by partial airway blockage in pigs.
49#
發(fā)表于 2025-3-29 23:57:52 | 只看該作者
50#
發(fā)表于 2025-3-30 06:44:50 | 只看該作者
 關于派博傳思  派博傳思旗下網站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網 吾愛論文網 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經驗總結 SCIENCEGARD IMPACTFACTOR 派博系數 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網安備110108008328) GMT+8, 2025-10-24 07:07
Copyright © 2001-2015 派博傳思   京公網安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
那曲县| 南和县| 广灵县| 密山市| 林州市| 通山县| 陇西县| 英超| 阿拉善盟| 清新县| 磐石市| 福海县| 东平县| 仙居县| 五台县| 仙游县| 万州区| 平度市| 东乌珠穆沁旗| 和田县| 十堰市| 湘西| 浙江省| 宝坻区| 潢川县| 柘城县| 张北县| 永德县| 海盐县| 成武县| 广汉市| 汉川市| 类乌齐县| 盐城市| 临朐县| 安宁市| 贵阳市| 高邮市| 昂仁县| 五华县| 高安市|